Clinical trial

Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia

NCT07288333

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-02-16

PhasePHASE2

Study timeline

Study start (actual)2026-02-16Date precision: day

Registry last updated2026-07-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

NBI-1117570DRUG

PlaceboDRUG

Sponsors & collaborators

Neurocrine Bioscienceslead sponsor

Mapped research locations

LondonUnited Kingdom1 OxfordUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07288333 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.